PITTSBURGH, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI), a leader in AI-driven drug discovery and biologics, today provided an update highlighting new successes with its drug ...
In a milestone for Alzheimer’s disease diagnosis and care, the U.S. Food and Drug Administration on May 16 cleared for marketing the first AD blood test. Fujirebio’s Lumipulse G p-tau217/Aβ42 ...
Illicitly manufactured fentanyl and amphetamine-type stimulants are major contributors to the opioid crisis in North America.
Findings showed testing with Elecsys pTau181 helped to rule out Alzheimer pathology with a 97.9% negative predictive value in this early disease-stage population. The Food and Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results